224 related articles for article (PubMed ID: 20930544)
1. Therapeutic targeting of C-terminal binding protein in human cancer.
Straza MW; Paliwal S; Kovi RC; Rajeshkumar B; Trenh P; Parker D; Whalen GF; Lyle S; Schiffer CA; Grossman SR
Cell Cycle; 2010 Sep; 9(18):3740-50. PubMed ID: 20930544
[TBL] [Abstract][Full Text] [Related]
2. An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis.
Kovi RC; Paliwal S; Pande S; Grossman SR
Cell Death Differ; 2010 Mar; 17(3):513-21. PubMed ID: 19798104
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
Korwar S; Morris BL; Parikh HI; Coover RA; Doughty TW; Love IM; Hilbert BJ; Royer WE; Kellogg GE; Grossman SR; Ellis KC
Bioorg Med Chem; 2016 Jun; 24(12):2707-15. PubMed ID: 27156192
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.
Hilbert BJ; Grossman SR; Schiffer CA; Royer WE
FEBS Lett; 2014 May; 588(9):1743-8. PubMed ID: 24657618
[TBL] [Abstract][Full Text] [Related]
5. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis.
Paliwal S; Pande S; Kovi RC; Sharpless NE; Bardeesy N; Grossman SR
Mol Cell Biol; 2006 Mar; 26(6):2360-72. PubMed ID: 16508011
[TBL] [Abstract][Full Text] [Related]
6. Incapacitating CtBP to kill cancer.
Zhao LZ; Chinnadurai G
Cell Cycle; 2010 Sep; 9(18):3645-6. PubMed ID: 20930508
[No Abstract] [Full Text] [Related]
7. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
Wang L; Zhou H; Wang Y; Cui G; Di LJ
Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.
Patel J; Baranwal S; Love IM; Patel NJ; Grossman SR; Patel BB
Cell Cycle; 2014; 13(22):3506-18. PubMed ID: 25483087
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided design of a high affinity inhibitor to human CtBP.
Hilbert BJ; Morris BL; Ellis KC; Paulsen JL; Schiffer CA; Grossman SR; Royer WE
ACS Chem Biol; 2015 Apr; 10(4):1118-27. PubMed ID: 25636004
[TBL] [Abstract][Full Text] [Related]
10. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
[TBL] [Abstract][Full Text] [Related]
11. C-terminal binding proteins are essential pro-survival factors that undergo caspase-dependent downregulation during neuronal apoptosis.
Stankiewicz TR; Schroeder EK; Kelsey NA; Bouchard RJ; Linseman DA
Mol Cell Neurosci; 2013 Sep; 56():322-332. PubMed ID: 23859824
[TBL] [Abstract][Full Text] [Related]
12. CPP-E1A fusion peptides inhibit CtBP-mediated transcriptional repression.
Blevins MA; Zhang C; Zhang L; Li H; Li X; Norris DA; Huang M; Zhao R
Mol Oncol; 2018 Aug; 12(8):1358-1373. PubMed ID: 29879296
[TBL] [Abstract][Full Text] [Related]
13. CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.
Dcona MM; Morris BL; Ellis KC; Grossman SR
Cancer Biol Ther; 2017 Jun; 18(6):379-391. PubMed ID: 28532298
[TBL] [Abstract][Full Text] [Related]
14. Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.
Dcona MM; Damle PK; Zarate-Perez F; Morris BL; Nawaz Z; Dennis MJ; Deng X; Korwar S; Singh SJ; Ellis KC; Royer WE; Bandyopadhyay D; Escalante C; Grossman SR
Mol Pharmacol; 2019 Jul; 96(1):99-108. PubMed ID: 31036695
[TBL] [Abstract][Full Text] [Related]
15. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs.
Grooteclaes M; Deveraux Q; Hildebrand J; Zhang Q; Goodman RH; Frisch SM
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4568-73. PubMed ID: 12676992
[TBL] [Abstract][Full Text] [Related]
16. c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP.
Wang SY; Iordanov M; Zhang Q
J Biol Chem; 2006 Nov; 281(46):34810-5. PubMed ID: 16984892
[TBL] [Abstract][Full Text] [Related]
17. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP.
Zhang Q; Yoshimatsu Y; Hildebrand J; Frisch SM; Goodman RH
Cell; 2003 Oct; 115(2):177-86. PubMed ID: 14567915
[TBL] [Abstract][Full Text] [Related]
18. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.
Paliwal S; Kovi RC; Nath B; Chen YW; Lewis BC; Grossman SR
Cancer Res; 2007 Oct; 67(19):9322-9. PubMed ID: 17909040
[TBL] [Abstract][Full Text] [Related]
19. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
20. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.
Zhang CL; McKinsey TA; Lu JR; Olson EN
J Biol Chem; 2001 Jan; 276(1):35-9. PubMed ID: 11022042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
